{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:53:49Z","timestamp":1773726829985,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00784-016-1762-y","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T21:21:17Z","timestamp":1456694477000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab"],"prefix":"10.1007","volume":"21","author":[{"given":"Akihiko","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Schmelzeisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pit Jacob","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"issue":"8","key":"1762_CR1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756\u2013765","journal-title":"N Engl J Med"},{"issue":"3","key":"1762_CR2","first-page":"209","volume":"36","author":"I Silva","year":"2011","unstructured":"Silva I, Branco JC (2011) Rank\/Rankl\/opg: literature review. Acta Reumatologica Portuguesa 36(3):209\u2013218","journal-title":"Acta Reumatologica Portuguesa"},{"issue":"35","key":"1762_CR3","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","volume":"28","author":"AT Stopeck","year":"2010","unstructured":"Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol Off J Am Soc Clin Oncol 28(35):5132\u20135139","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10","key":"1762_CR4","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons 72(10):1938\u20131956","journal-title":"J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons"},{"issue":"2 Suppl 1","key":"1762_CR5","first-page":"S95","volume":"28","author":"JP Brown","year":"2006","unstructured":"Brown JP, Fortier M, Frame H, Lalonde A, Papaioannou A, Senikas V, Yuen CK (2006) Canadian consensus conference on osteoporosis, 2006 update. J Obstet Gynaecol Can JOGC J d'obstetrique et gynecologie du CanadaJOGC 28(2 Suppl 1):S95\u2013112","journal-title":"J Obstet Gynaecol Can JOGC J d'obstetrique et gynecologie du CanadaJOGC"},{"issue":"Suppl 1","key":"1762_CR6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.3816\/CBC.2007.s.002","volume":"7","author":"A Lipton","year":"2007","unstructured":"Lipton A (2007) Efficacy and safety of intravenous bisphosphonates in patients with bone metastases caused by metastatic breast cancer. Clin Breast Cancer 7(Suppl 1):S14\u2013S20","journal-title":"Clin Breast Cancer"},{"issue":"20","key":"1762_CR7","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1158\/1078-0432.CCR-07-5234","volume":"14","author":"A Lipton","year":"2008","unstructured":"Lipton A, Steger GG, Figueroa J, Alvarado C, Solal-Celigny P, Body JJ, de Boer R, Berardi R, Gascon P, Tonkin KS (2008) Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy. Clin Cancer Res Off J Am Assoc Cancer Res 14(20):6690\u20136696","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"1762_CR8","first-page":"331","volume":"7","author":"AJ Yee","year":"2012","unstructured":"Yee AJ, Raje NS (2012) Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients. Clin Interv Aging 7:331\u2013338","journal-title":"Clin Interv Aging"},{"key":"1762_CR9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/TCRM.S24239","volume":"8","author":"AD Anastasilakis","year":"2012","unstructured":"Anastasilakis AD, Toulis KA, Polyzos SA, Anastasilakis CD, Makras P (2012) Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab. Ther Clin Risk Manag 8:295\u2013306","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"1762_CR10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons 61(9):1115\u20131117","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons"},{"issue":"1","key":"1762_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00784-009-0294-0","volume":"14","author":"J Rustemeyer","year":"2010","unstructured":"Rustemeyer J, Bremerich A (2010) Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature. Clin Oral Investig 14(1):59\u201364","journal-title":"Clin Oral Investig"},{"issue":"5","key":"1762_CR12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","volume":"68","author":"TL Aghaloo","year":"2010","unstructured":"Aghaloo TL, Felsenfeld AL, Tetradis S (2010) Osteonecrosis of the jaw in a patient on Denosumab. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons 68(5):959\u2013963","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons"},{"issue":"5","key":"1762_CR13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol Off J Eur Soc Med Oncol\/ESMO 23(5):1341\u20131347","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"7","key":"1762_CR14","first-page":"1391","volume":"35","author":"AA Khan","year":"2008","unstructured":"Khan AA, Sandor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Dempster DW (2008) Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 35(7):1391\u20131397","journal-title":"J Rheumatol"},{"issue":"1","key":"1762_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, Bareggi C, Ascani L, Cislaghi E (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol Off J Eur Soc Med Oncol\/ESMO 20(1):137\u2013145","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"3","key":"1762_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","volume":"35","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J J Aust Soc Endodontol Inc 35(3):119\u2013130","journal-title":"Aust Endod J J Aust Soc Endodontol Inc"},{"issue":"28","key":"1762_CR17","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","volume":"26","author":"A Kyrgidis","year":"2008","unstructured":"Kyrgidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas I, Teleioudis Z, Patrikidou A, Triaridis S (2008) Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol Off J Am Soc Clin Oncol 26(28):4634\u20134638","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"1762_CR18","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","volume":"71","author":"C Tsao","year":"2013","unstructured":"Tsao C, Darby I, Ebeling PR, Walsh K, O'Brien-Simpson N, Reynolds E, Borromeo G (2013) Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons 71(8):1360\u20131366","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons"},{"issue":"12","key":"1762_CR19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ncpendmet0348","volume":"2","author":"D Felsenberg","year":"2006","unstructured":"Felsenberg D (2006) Osteonecrosis of the jaw\u2014a potential adverse effect of bisphosphonate treatment. Nat Clin Pract Endocrinol Metab 2(12):662\u2013663","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"32","key":"1762_CR20","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol Off J Am Soc Clin Oncol 27(32):5356\u20135362","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"1762_CR21","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.1016\/j.oooo.2012.08.442","volume":"117","author":"MJ Heufelder","year":"2014","unstructured":"Heufelder MJ, Hendricks J, Remmerbach T, Frerich B, Hemprich A, Wilde F (2014) Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 117(6):e429\u2013e435","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"1762_CR22","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00198-012-2239-8","volume":"24","author":"M Mozzati","year":"2013","unstructured":"Mozzati M, Arata V, Gallesio G (2013) Tooth extraction in osteoporotic patients taking oral bisphosphonates. Osteoporos Int J Established Result Cooperation Between Eur Found Osteoporos Nat Osteoporos Found USA 24(5):1707\u20131712","journal-title":"Osteoporos Int J Established Result Cooperation Between Eur Found Osteoporos Nat Osteoporos Found USA"},{"issue":"6","key":"1762_CR23","first-page":"847","volume":"43","author":"S Otto","year":"2015","unstructured":"Otto S, Troltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C (2015) Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development? J Craniomaxillofac Surg Off Publ Eur Assoc Craniomaxillofac Surg 43(6):847\u2013854","journal-title":"J Craniomaxillofac Surg Off Publ Eur Assoc Craniomaxillofac Surg"},{"key":"1762_CR24","unstructured":"Groetz KA, Piesold J-U, Al-Nawas B (2012) Bisphosphonat-assoziierte Kiefernekrose (BPONJ) und andere Medikamenten-assoziierte Kiefernekrosen. http:\/\/www.awmf.org ; In AWMF online:"},{"issue":"19","key":"1762_CR25","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","volume":"94","author":"F Saad","year":"2009","unstructured":"Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B (2009) A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 94(19):1458\u20131468","journal-title":"J Natl Cancer Inst"},{"key":"1762_CR26","first-page":"b147","volume":"77","author":"R Bonacina","year":"2011","unstructured":"Bonacina R, Mariani U, Villa F, Villa A (2011) Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients. J Can Dent Assoc 77:b147","journal-title":"J Can Dent Assoc"},{"issue":"1","key":"1762_CR27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/annonc\/mdr039","volume":"23","author":"AM Vandone","year":"2012","unstructured":"Vandone AM, Donadio M, Mozzati M, Ardine M, Polimeni MA, Beatrice S, Ciuffreda L, Scoletta M (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol Off J Eur Soc Med Oncol\/ESMO 23(1):193\u2013200","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"1","key":"1762_CR28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.joms.2009.07.068","volume":"68","author":"G Lodi","year":"2010","unstructured":"Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A (2010) Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons 68(1):107\u2013110","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons"},{"issue":"6","key":"1762_CR29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.joms.2013.01.006","volume":"71","author":"M Scoletta","year":"2013","unstructured":"Scoletta M, Arata V, Arduino PG, Lerda E, Chiecchio A, Gallesio G, Scully C, Mozzati M (2013) Tooth extractions in intravenous bisphosphonate-treated patients: a refined protocol. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons 71(6):994\u2013999","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons"},{"issue":"9","key":"1762_CR30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.oraloncology.2012.03.009","volume":"48","author":"M Mozzati","year":"2012","unstructured":"Mozzati M, Arata V, Gallesio G (2012) Tooth extraction in patients on zoledronic acid therapy. Oral Oncol 48(9):817\u2013821","journal-title":"Oral Oncol"},{"issue":"11","key":"1762_CR31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","volume":"41","author":"T Yamazaki","year":"2012","unstructured":"Yamazaki T, Yamori M, Ishizaki T, Asai K, Goto K, Takahashi K, Nakayama T, Bessho K (2012) Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. Int J Oral Maxillofac Surg 41(11):1397\u20131403","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"4","key":"1762_CR32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.joms.2009.10.026","volume":"68","author":"G Saia","year":"2010","unstructured":"Saia G, Blandamura S, Bettini G, Tronchet A, Totola A, Bedogni G, Ferronato G, Nocini PF, Bedogni A (2010) Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons 68(4):797\u2013804","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons"},{"issue":"11","key":"1762_CR33","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.joms.2010.07.017","volume":"68","author":"S Otto","year":"2010","unstructured":"Otto S, Pautke C, Opelz C, Westphal I, Drosse I, Schwager J, Bauss F, Ehrenfeld M, Schieker M (2010) Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons 68(11):2837\u20132845","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons"},{"issue":"10","key":"1762_CR34","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.joms.2011.02.059","volume":"69","author":"P Lopez-Jornet","year":"2011","unstructured":"Lopez-Jornet P, Camacho-Alonso F, Martinez-Canovas A, Molina-Minano F, Gomez-Garcia F, Vicente-Ortega V (2011) Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: a study of the changes in the jaws. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons 69(10):2488\u20132493","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons"},{"issue":"10","key":"1762_CR35","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/jbmr.1669","volume":"27","author":"JI Aguirre","year":"2012","unstructured":"Aguirre JI, Akhter MP, Kimmel DB, Pingel JE, Williams A, Jorgensen M, Kesavalu L, Wronski TJ (2012) Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis. J Bone Miner Res Off J Am Soc Bone Miner Res 27(10):2130\u20132143","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"7","key":"1762_CR36","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jbmr.1894","volume":"28","author":"B Kang","year":"2013","unstructured":"Kang B, Cheong S, Chaichanasakul T, Bezouglaia O, Atti E, Dry SM, Pirih FQ, Aghaloo TL, Tetradis S (2013) Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice. J Bone Miner Res Off J Am Soc Bone Miner Res 28(7):1631\u20131640","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"4","key":"1762_CR37","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00784-011-0596-x","volume":"16","author":"J Lemound","year":"2012","unstructured":"Lemound J, Eckardt A, Kokemuller H, von See C, Voss PJ, Tavassol F, Rucker M, Rana M, Gellrich NC (2012) Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap. Clin Oral Investig 16(4):1143\u20131152","journal-title":"Clin Oral Investig"},{"issue":"10","key":"1762_CR38","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.joms.2011.02.037","volume":"69","author":"F Wilde","year":"2011","unstructured":"Wilde F, Hendricks J, Riese C, Pausch NC, Schramm A, Heufelder M (2011) Bone regeneration without bone grafting after resection of a segment of the mandible to treat bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons 69(10):2657\u20132662","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surgeons"},{"issue":"8","key":"1762_CR39","first-page":"719","volume":"40","author":"PJ Voss","year":"2012","unstructured":"Voss PJ, Joshi Oshero J, Kovalova-Muller A, Veigel Merino EA, Sauerbier S, Al-Jamali J, Lemound J, Metzger MC, Schmelzeisen R (2012) Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients. J Craniomaxillofac Surg Off Publ Eur Assoc Craniomaxillofac Surg 40(8):719\u2013725","journal-title":"J Craniomaxillofac Surg Off Publ Eur Assoc Craniomaxillofac Surg"},{"issue":"5","key":"1762_CR40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons 62(5):527\u2013534","journal-title":"J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons"},{"issue":"11","key":"1762_CR41","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons 63(11):1567\u20131575","journal-title":"J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons"},{"issue":"18","key":"1762_CR42","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1055\/s-2007-979369","volume":"132","author":"R Bartl","year":"2007","unstructured":"Bartl R (2007) Practical guidelines for the management of osteoporosis\u2013evidence-based and cost-effective. Deutsche Medizinische Wochenschrift (1946) 132(18):995\u2013999","journal-title":"Deutsche Medizinische Wochenschrift (1946)"},{"issue":"7","key":"1762_CR43","first-page":"694","volume":"41","author":"S Otto","year":"2013","unstructured":"Otto S, Baumann S, Ehrenfeld M, Pautke C (2013) Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection. J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons 41(7):694\u2013698","journal-title":"J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons"},{"issue":"2","key":"1762_CR44","first-page":"95","volume":"36","author":"MH Abu-Id","year":"2008","unstructured":"Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PA, Kreusch T (2008) \u201cBis-phossy jaws\u201d\u2014high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons 36(2):95\u2013103","journal-title":"J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons"},{"issue":"4","key":"1762_CR45","first-page":"272","volume":"39","author":"S Otto","year":"2011","unstructured":"Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mucke T, Mast G, Kohnke R, Volkmer E (2011) Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence\u2014a multi-centre study. J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons 39(4):272\u2013277","journal-title":"J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons"},{"issue":"5","key":"1762_CR46","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.joms.2008.12.057","volume":"67","author":"DC Stanton","year":"2009","unstructured":"Stanton DC, Balasanian E (2009) Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons 67(5):943\u2013950","journal-title":"J Oral Craniomaxillofac Surg Off J Am Assoc Oral Craniomaxillofac Surgeons"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1762-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-016-1762-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1762-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1762-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:33:11Z","timestamp":1559097191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-016-1762-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,29]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s00784-016-1762-y","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,29]]}}}